title: [Glycated hemoglobin: a new screening tool?].
abstract: Evaluation of mean glycemic control in diabetic patients is possible with the measure of glycosylated hemoglobin (HbA1c). Recently, new recommendations were made giving this test a diagnostic value for diabetes. HbA1c is the best prediction parameter of complications linked to diabetes; its measure is relatively accurate and simple. Nevertheless, the threshold value is arbitrary and a standardized method of dosage still remains limited. The aim of this article is to analyze the implementation of this dosage, its advantages and disadvantages as a diagnostic tool in comparison with plasma glycaemia, and current data concerning its sensibility, specificity and clinical implication.
authors.affiliation: Service de médecine interne générale, HUG, 1211 Geneve 14. Karim.Gariani@hcuge.ch
authors.forename: K
authors.initials: K
authors.lastname: Gariani
authors.forename: C
authors.initials: C
authors.lastname: Tran
authors.forename: J
authors.initials: J
authors.lastname: Philippe
mesh_terms: D003920:Diabetes Mellitus / Q000097:blood / Q000175:diagnosis*; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans
chemical_list: D006442:Glycated Hemoglobin; C517652:hemoglobin A1c protein, human